This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Jan 15;174(2):66-7.

doi: 10.5694/j.1326-5377.2001.tb143155.x.

Normocholesterolaemic dyslipidaemia: is there a role for fibrates?

G F Watts, S B Dimmitt, P J Barter

PMID: 11245504
DOI: 10.5694/j.1326-5377.2001.tb143155.x

Review

Normocholesterolaemic dyslipidaemia: is there a role for fibrates?

G F Watts et al. Med J Aust. 2001.

. 2001 Jan 15;174(2):66-7.

doi: 10.5694/j.1326-5377.2001.tb143155.x.

Authors

G F Watts, S B Dimmitt, P J Barter

PMID: 11245504
DOI: 10.5694/j.1326-5377.2001.tb143155.x

No abstract available

PubMed Disclaimer

Comment in

Normocholesterolaemic dyslipidaemia: is there a role for fibrates?
Tallis GA. Tallis GA. Med J Aust. 2001 Jun 4;174(11):610; author reply 611. doi: 10.5694/j.1326-5377.2001.tb143458.x. Med J Aust. 2001. PMID: 11453340 No abstract available.
Normocholesterolaemic dysslipidaemia: is there a role for fibrates?
Hamilton-Craig I. Hamilton-Craig I. Med J Aust. 2001 Jun 4;174(11):610; author reply 611. doi: 10.5694/j.1326-5377.2001.tb143459.x. Med J Aust. 2001. PMID: 11453341 No abstract available.

Similar articles

Normocholesterolaemic dysslipidaemia: is there a role for fibrates?
Hamilton-Craig I. Hamilton-Craig I. Med J Aust. 2001 Jun 4;174(11):610; author reply 611. doi: 10.5694/j.1326-5377.2001.tb143459.x. Med J Aust. 2001. PMID: 11453341 No abstract available.
Normocholesterolaemic dyslipidaemia: is there a role for fibrates?
Tallis GA. Tallis GA. Med J Aust. 2001 Jun 4;174(11):610; author reply 611. doi: 10.5694/j.1326-5377.2001.tb143458.x. Med J Aust. 2001. PMID: 11453340 No abstract available.
A case for lipid-lowering?
Durrington P. Durrington P. Diabet Med. 2000 Sep;17 Suppl 2:4-5. doi: 10.1046/j.1464-5491.2000.00361-3.x. Diabet Med. 2000. PMID: 11048824 No abstract available.
Fibrates and high-dose statins to prevent coronary heart disease events.
Jones PH. Jones PH. Curr Cardiol Rep. 1999 Sep;1(3):223-4. doi: 10.1007/s11886-999-0026-8. Curr Cardiol Rep. 1999. PMID: 10980845 Review. No abstract available.
Selection of appropriate type and intensity of lipid-lowering therapy.
Tikkanen MJ. Tikkanen MJ. Curr Opin Lipidol. 1995 Dec;6(6):360-4. doi: 10.1097/00041433-199512000-00005. Curr Opin Lipidol. 1995. PMID: 8750248 Review.

See all similar articles

Cited by

Treating patients with low high-density lipoprotein cholesterol: choices, issues and opportunities.
Watts GF. Watts GF. Curr Control Trials Cardiovasc Med. 2001;2(3):118-122. doi: 10.1186/cvm-2-3-118. Curr Control Trials Cardiovasc Med. 2001. PMID: 11806784 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information